TB vaccine BCG shows promise to fight Covid-19: Study
Sydney researchers are taking an innovative approach to designing potential COVID-19 vaccines – using a tuberculosis vaccine BCG to deliver components of the SARS-CoV-2 virus. Early results from pre-clinical testing in mice are promising. Two other separate studies also found the inexpensive and widely-used Bacillus Calmette–Guerin (BCG) vaccine that protectsRead More →